Our organisation
The Fraunhofer-Gesellschaft is the world’s leading non-profit organization for applied research. By prioritizing key technologies for the future and commercializing its findings in business and industry, it plays a major role in the innovation process. As one of 76 institutes and research units, the Fraunhofer Institute for Biomedical Engineering IBMT is offering solutions for individual tasks in the areas of e.g. biomedical engineering, cellular biotechnology as well as (nano)toxicology. The institute promotes the technology transfer to medicine and various areas of industry.
Our role in the project
Fraunhofer, with its Institute for Biomedical Engineering IBMT, will be responsible for the development of innovative models for human health assessment. As WP4 leader, Fraunhofer will mainly be involved in WP4 with the main tasks of performance of in vitro assays (barrier transport studies and different toxicological endpoints) and the setup of new fluidic in vitro models.
Fraunhofer will also take part in WP3, 8 and 9.
